Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis

International Journal of Neuroscience

Volumn 121, Issue 8, 2011, Pages 477-479

  Stich, Oliver ^a   Murek, Constanze ^a   Rasiah, Christiane ^b   Rauer, Sebastian ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RAVO DIAGNOSTIKA GMBH   (Germany)

Author keywords

Antineuronal antibodies; Cancer; Malignancy; Multiple sclerosis; Paraneoplastic neurological syndromes

Indexed keywords

AMPHIPHYSIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HU ANTIBODY;

ANTIBODY SPECIFICITY; CANCER INCIDENCE; CLINICALLY ISOLATED SYNDROME; DISEASE ASSOCIATION; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMMOPATHY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOREACTIVITY; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARANEOPLASTIC NEUROPATHY; PROSTATE CANCER; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SYNDROME;

ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; MALE; MASS SCREENING; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS;

EID: 79960795500     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.580865     Document Type: Review

References (13)

1. Cross, S. A., Salomao, D. R., Parisi, J. E., Kryzer, T. J., Bradley, E. A., Mines, J. A., et al. (2003).Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Annals of Neurology, 54, 38-50.
2. Ducray, F., Roos-Weil, R., Garcia, P. Y., Slesari, J., Heinzlef, O., Chatelain,D., et al. (2007).Devics syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 325-327.
3. Graus, F., Delattre, J. Y., Antoine, J. C., Dalmau, J., Giometto, B., Grisold, W., et al. (2004).Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1135-1140.
4. Graus, F., Saiz, A., & Dalmau, J. (2010).Antibodies and neuronal autoimmune disorders of the CNS. Journal of Neurology, 257, 509-517.
5. Jaster, J.H., Zamecnik, J., Bartos, A., & Smith, T.W. (2005).Demyelination in the brain as a paraneoplastic disorder: Candidates include some cases ofmultiple sclerosis. Neuroepidemiology, 25,212.
6. Midgard, R., Glattre, E., Grønning, M., Riise, T., Edland, A., & Nyland, H. (1996).Multiple sclerosis and cancer in Norway. A retrospective cohort study. Acta Neurologica Scandinavica, 93, 411-415.
7. Møller, H., Kneller, R. W., Boice, J. D., Jr., & Olsen, J. H. (1991). Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurologica Scandinavica, 84, 214-220
8. Monstad, S. E., Knudsen, A., Salvesen, H. B., Aarseth, J. H., &Vedeler, C. A. (2009).Onconeural antibodies in sera from patients with various types of tumours. Cancer Immunology, Immunotherapy, 58, 1795-800.
9. Nielsen, N. M., Rostgaard, K., Rasmussen, S., Koch-Henriksen, N., Storm, H. H., Melbye, M., et al. (2006).Cancer risk among patients with multiple sclerosis: a population-based register study. International Journal of Cancer, 118, 979-984.
10. Stich, O., Kleer, B., & Rauer, S. (2007).Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 883-885.
11. Sueoka, E., Yukitake, M., Iwanaga, K., Sueoka, N., Aihara, T., & Kuroda, Y. (2004).Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF ofMS patients. Annals of Neurology, 56, 778-786.
12. Torkildsen, N. G., Lie, S. A., Aarseth, J. H., Nyland, H., & Myhr, K. M. (2007).Cancer-related mortality among patients with multiple sclerosis, 1953-2003. Multiple sclerosis, 13, s97, p327.
13. Wong, K., Poon, P., Berry, K., Coppin, C., & Kostashuk, E. (1998). Paraneoplastic demyelinating disorder in the brain of a patient with seminoma. Journal of Computer Assisted Tomography, 22, 136-138.